Variations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy: an open question
about
Maximal testosterone suppression in prostate cancer--free vs total testosteroneEffects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancersExtended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dl.Steroid Hormone Receptors as Potential Mediators of the Clinical Effects of Dutasteride: A Prospective, Randomized, Double-Blind Study.
P2860
Variations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy: an open question
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Variations of serum testostero ...... mone therapy: an open question
@ast
Variations of serum testostero ...... mone therapy: an open question
@en
Variations of serum testostero ...... mone therapy: an open question
@nl
type
label
Variations of serum testostero ...... mone therapy: an open question
@ast
Variations of serum testostero ...... mone therapy: an open question
@en
Variations of serum testostero ...... mone therapy: an open question
@nl
prefLabel
Variations of serum testostero ...... mone therapy: an open question
@ast
Variations of serum testostero ...... mone therapy: an open question
@en
Variations of serum testostero ...... mone therapy: an open question
@nl
P356
P1476
Variations of serum testostero ...... mone therapy: an open question
@en
P2093
L. O. Reis
P356
10.1530/ERC-12-0040
P407
P577
2012-05-24T00:00:00Z